CJC-1295 NO DAC - 5 mg

CJC-1295 NO DAC — 5 mg

CJC-1295 NO DAC is a synthetic peptide widely studied in research settings for its selective interaction with growth hormone–releasing hormone (GHRH) pathways without long-acting modifications. Researchers examine it for how it stimulates natural, pulsatile growth hormone signaling, aligns with circadian secretion patterns, and influences downstream physiological markers without broadly activating other endocrine pathways.

Key Research Observations on CJC-1295 NO DAC

Pulsatile growth hormone release
Research literature describes CJC-1295 NO DAC as a short-acting GHRH analog that promotes growth hormone secretion in discrete pulses, closely resembling endogenous growth hormone release patterns.

Minimal impact on cortisol and prolactin
Studies note CJC-1295 NO DAC’s pathway specificity, observing little to no elevation in cortisol, prolactin, or other non–growth hormone pituitary hormones compared to less selective compounds.

Role in circadian hormone patterns
Scientific investigation explores how CJC-1295 NO DAC may align with natural growth hormone pulse timing, particularly during sleep-associated secretion windows.

Interest in recovery and metabolic signaling research
Academic and preclinical research examines CJC-1295 NO DAC for its downstream signaling effects related to tissue recovery, protein synthesis pathways, and metabolic regulation in controlled research settings.